Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases JOURNAL OF GASTROINTESTINAL SURGERY Margonis, G., Sasaki, K., Kim, Y., Samaha, M., Buettner, S., Amini, N., Antoniou, E., Pawlik, T. M. 2016; 20 (11): 1821-1829


The interplay of tumor biology and surgical margin status after resection for colorectal liver metastasis (CRLM) remains controversial. Consequently, we sought to determine the impact of surgical margin status on overall survival (OS) stratified by KRAS mutational status.Four hundred eighty-five patients with known KRAS mutational status were identified. Clinicopathologic and long-term survival data were collected and assessed.On pathology, most patients (n?=?380; 78.3 %) had an R0 margin, while 105 (21.7 %) had an R1. Roughly two thirds of tumors were KRAS wild type (wtKRAS) (n?=?307, 63.3 %), while 36.7 % (n?=?178) had KRAS mutations (mutKRAS). Median and 5-year OS of the entire cohort was 65.8 months and 53.8 %, respectively. An R1 resection was associated with worse 5-year OS compared with R0 (42.4 % vs. 57.1 %; hazard ratio (HR) 1.82, 95 % CI 1.28-2.57; P?=?0.001). After controlling for KRAS status, the survival benefit associated with an R0 resection persisted only among patients with wtKRAS tumors (HR 2.16, 95 % CI 1.42-3.30; P?

View details for DOI 10.1007/s11605-016-3198-8

View details for Web of Science ID 000387032200006

View details for PubMedID 27384430